Search research articles
Contact Us
Filters
Showing results (91-100 of 112) with videos related to
Page
of 12
Sort By:
Nature Communications
|
March 21, 2024
A structure-based designed small molecule depletes hRpn13<sup>Pru</sup> and a select group of KEN box proteins
Xiuxiu Lu, Monika Chandravanshi, Venkata R Sabbasani, et al.
Cancer Discovery
|
April 28, 2017
PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
Berkley E Gryder, Marielle E Yohe, Hsien-Chao Chou, et al.
Familial Cancer
|
July 3, 2021
Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family
Kevin M Brown, Mai Xu, Michael Sargen, et al.
Journal for Immunotherapy of Cancer
|
July 1, 2026
ENPP3 CAR T cells combined with CD206 modulation suppress adrenocortical carcinoma
Reona Okada, Arnulfo Mendoza, Darryl Nousome, et al.
Biorxiv : the Preprint Server for Biology
|
April 27, 2026
Single-cell full-length transcriptome of human lung reveals genetic effects on isoform regulation beyond gene-level expression
Bolun Li, Thong Luong, Elelta Sisay, et al.
Human Molecular Genetics
|
February 8, 2017
Functional characterization of a chr13q22.1 pancreatic cancer risk locus reveals long-range interaction and allele-specific effects on DIS3 expression
Jason W Hoskins, Abdisamad Ibrahim, Mickey A Emmanuel, et al.
Elife
|
October 28, 2020
A small protein encoded by a putative lncRNA regulates apoptosis and tumorigenicity in human colorectal cancer cells
Xiao Ling Li, Lőrinc Pongor, Wei Tang, et al.
The Journal of Clinical Investigation
|
July 8, 2025
NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STING
Yoo Sun Kim, Barzin Y Nabet, Briana N Cortez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2022
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
John A Ligon, R Taylor Sundby, Mary F Wedekind, et al.
Biorxiv : the Preprint Server for Biology
|
May 8, 2026
Functional characterization of the 9q34.13 locus identifies <i>RAPGEF1</i> as modulating risk for melanoma and nevi via RAS activation
Rohit Thakur, Mai Xu, Alexandra M Thornock, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 112) with videos related to
Sort By:
Page
of 12
Nature Communications
|
March 21, 2024
A structure-based designed small molecule depletes hRpn13<sup>Pru</sup> and a select group of KEN box proteins
Xiuxiu Lu, Monika Chandravanshi, Venkata R Sabbasani, et al.
Cancer Discovery
|
April 28, 2017
PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
Berkley E Gryder, Marielle E Yohe, Hsien-Chao Chou, et al.
Familial Cancer
|
July 3, 2021
Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family
Kevin M Brown, Mai Xu, Michael Sargen, et al.
Journal for Immunotherapy of Cancer
|
July 1, 2026
ENPP3 CAR T cells combined with CD206 modulation suppress adrenocortical carcinoma
Reona Okada, Arnulfo Mendoza, Darryl Nousome, et al.
Biorxiv : the Preprint Server for Biology
|
April 27, 2026
Single-cell full-length transcriptome of human lung reveals genetic effects on isoform regulation beyond gene-level expression
Bolun Li, Thong Luong, Elelta Sisay, et al.
Human Molecular Genetics
|
February 8, 2017
Functional characterization of a chr13q22.1 pancreatic cancer risk locus reveals long-range interaction and allele-specific effects on DIS3 expression
Jason W Hoskins, Abdisamad Ibrahim, Mickey A Emmanuel, et al.
Elife
|
October 28, 2020
A small protein encoded by a putative lncRNA regulates apoptosis and tumorigenicity in human colorectal cancer cells
Xiao Ling Li, Lőrinc Pongor, Wei Tang, et al.
The Journal of Clinical Investigation
|
July 8, 2025
NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STING
Yoo Sun Kim, Barzin Y Nabet, Briana N Cortez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2022
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
John A Ligon, R Taylor Sundby, Mary F Wedekind, et al.
Biorxiv : the Preprint Server for Biology
|
May 8, 2026
Functional characterization of the 9q34.13 locus identifies <i>RAPGEF1</i> as modulating risk for melanoma and nevi via RAS activation
Rohit Thakur, Mai Xu, Alexandra M Thornock, et al.
Page
of 12